hims glp-1 news The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted telehealth company & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the Novo Nordisk Forms GLP-1 Partnership
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20




























